693.85 USD
+2.8 (+0.41%)
690 USD
-3.85 (-0.55%)
Overall IDXX gets a fundamental rating of 7 out of 10. We evaluated IDXX against 186 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making IDXX a very profitable company, without any liquidiy or solvency issues. IDXX is not valued too expensively and it also shows a decent growth rate. These ratings could make IDXX a good candidate for quality investing.
1. Profitability
1.1 Basic Checks
- In the past year IDXX was profitable.
- IDXX had a positive operating cash flow in the past year.
- IDXX had positive earnings in each of the past 5 years.
- In the past 5 years IDXX always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 30.34%, IDXX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
- IDXX's Return On Equity of 65.81% is amongst the best of the industry. IDXX outperforms 100.00% of its industry peers.
- IDXX has a Return On Invested Capital of 40.25%. This is amongst the best in the industry. IDXX outperforms 100.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for IDXX is significantly above the industry average of 8.84%.
- The last Return On Invested Capital (40.25%) for IDXX is above the 3 year average (35.08%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| ROIC | 40.25% |
ROA(3y)25.87%
ROA(5y)26.7%
ROE(3y)74.71%
ROE(5y)84.83%
ROIC(3y)35.08%
ROIC(5y)36.07%
1.3 Margins
- Looking at the Profit Margin, with a value of 24.65%, IDXX belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
- In the last couple of years the Profit Margin of IDXX has grown nicely.
- The Operating Margin of IDXX (31.34%) is better than 98.92% of its industry peers.
- IDXX's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 61.72%, IDXX is in the better half of the industry, outperforming 63.44% of the companies in the same industry.
- IDXX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 31.34% | ||
| PM (TTM) | 24.65% | ||
| GM | 61.72% |
OM growth 3Y0.02%
OM growth 5Y4.78%
PM growth 3Y-0.56%
PM growth 5Y5.09%
GM growth 3Y1.27%
GM growth 5Y1.47%
2. Health
2.1 Basic Checks
- IDXX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- Compared to 1 year ago, IDXX has less shares outstanding
- Compared to 5 years ago, IDXX has less shares outstanding
- Compared to 1 year ago, IDXX has an improved debt to assets ratio.
2.2 Solvency
- IDXX has an Altman-Z score of 23.26. This indicates that IDXX is financially healthy and has little risk of bankruptcy at the moment.
- IDXX has a Altman-Z score of 23.26. This is amongst the best in the industry. IDXX outperforms 96.24% of its industry peers.
- The Debt to FCF ratio of IDXX is 1.04, which is an excellent value as it means it would take IDXX, only 1.04 years of fcf income to pay off all of its debts.
- IDXX's Debt to FCF ratio of 1.04 is amongst the best of the industry. IDXX outperforms 90.32% of its industry peers.
- IDXX has a Debt/Equity ratio of 0.53. This is a neutral value indicating IDXX is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.53, IDXX perfoms like the industry average, outperforming 40.32% of the companies in the same industry.
- Even though the debt/equity ratio score it not favorable for IDXX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 1.04 | ||
| Altman-Z | 23.26 |
ROIC/WACC3.87
WACC10.41%
2.3 Liquidity
- IDXX has a Current Ratio of 1.18. This is a normal value and indicates that IDXX is financially healthy and should not expect problems in meeting its short term obligations.
- IDXX's Current ratio of 1.18 is on the low side compared to the rest of the industry. IDXX is outperformed by 81.72% of its industry peers.
- A Quick Ratio of 0.87 indicates that IDXX may have some problems paying its short term obligations.
- With a Quick ratio value of 0.87, IDXX is not doing good in the industry: 80.11% of the companies in the same industry are doing better.
- The current and quick ratio evaluation for IDXX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 15.16% over the past year.
- The Earnings Per Share has been growing by 18.18% on average over the past years. This is quite good.
- The Revenue has grown by 8.39% in the past year. This is quite good.
- IDXX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.12% yearly.
EPS 1Y (TTM)15.16%
EPS 3Y9.32%
EPS 5Y18.18%
EPS Q2Q%21.43%
Revenue 1Y (TTM)8.39%
Revenue growth 3Y6.62%
Revenue growth 5Y10.12%
Sales Q2Q%13.29%
3.2 Future
- Based on estimates for the next years, IDXX will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.18% on average per year.
- Based on estimates for the next years, IDXX will show a quite strong growth in Revenue. The Revenue will grow by 9.43% on average per year.
EPS Next Y16.89%
EPS Next 2Y14.65%
EPS Next 3Y14.13%
EPS Next 5Y14.18%
Revenue Next Year10.46%
Revenue Next 2Y9.59%
Revenue Next 3Y9.39%
Revenue Next 5Y9.43%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 55.02, the valuation of IDXX can be described as expensive.
- 69.35% of the companies in the same industry are more expensive than IDXX, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 27.21. IDXX is valued rather expensively when compared to this.
- IDXX is valuated quite expensively with a Price/Forward Earnings ratio of 46.92.
- Based on the Price/Forward Earnings ratio, IDXX is valued a bit cheaper than 69.89% of the companies in the same industry.
- IDXX is valuated expensively when we compare the Price/Forward Earnings ratio to 24.26, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.02 | ||
| Fwd PE | 46.92 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, IDXX is valued a bit cheaper than 68.28% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, IDXX is valued a bit cheaper than the industry average as 73.12% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.93 | ||
| EV/EBITDA | 38.37 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The excellent profitability rating of IDXX may justify a higher PE ratio.
- IDXX's earnings are expected to grow with 14.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.26
PEG (5Y)3.03
EPS Next 2Y14.65%
EPS Next 3Y14.13%
5. Dividend
5.1 Amount
- No dividends for IDXX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IDEXX LABORATORIES INC / IDXX FAQ
What is the ChartMill fundamental rating of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a fundamental rating of 7 / 10 to IDXX.
What is the valuation status of IDEXX LABORATORIES INC (IDXX) stock?
ChartMill assigns a valuation rating of 4 / 10 to IDEXX LABORATORIES INC (IDXX). This can be considered as Fairly Valued.
Can you provide the profitability details for IDEXX LABORATORIES INC?
IDEXX LABORATORIES INC (IDXX) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IDEXX LABORATORIES INC (IDXX) stock?
The Price/Earnings (PE) ratio for IDEXX LABORATORIES INC (IDXX) is 55.02 and the Price/Book (PB) ratio is 35.49.
What is the expected EPS growth for IDEXX LABORATORIES INC (IDXX) stock?
The Earnings per Share (EPS) of IDEXX LABORATORIES INC (IDXX) is expected to grow by 16.89% in the next year.